Asosiy kontentga oʻtish
Maqola

Musculoskeletal Consequences of COVID-19

Nathaniel P. DisserHospital for Special Surgery, New York, NYAndrea J. De MicheliDepartment of Physiology and Biophysics, Weill Cornell Medical College, New York, NYMartin M. SchonkInvestigation performed at the Hospital for Special Surgery, New York, and Weill Cornell Medical College, New York, NYMaxwell A. KonnarisInvestigation performed at the Hospital for Special Surgery, New York, and Weill Cornell Medical College, New York, NYAlexander PiacentiniInvestigation performed at the Hospital for Special Surgery, New York, and Weill Cornell Medical College, New York, NYDaniel L. EdonInvestigation performed at the Hospital for Special Surgery, New York, and Weill Cornell Medical College, New York, NYBrett G. ToresdahlHospital for Special Surgery, New York, NYScott A. RodeoInvestigation performed at the Hospital for Special Surgery, New York, and Weill Cornell Medical College, New York, NYEllen CaseyHospital for Special Surgery, New York, NYChristopher L. MendiasDepartment of Physiology and Biophysics, Weill Cornell Medical College, New York, NY
2020en
ABI

Annotatsiya

Coronavirus disease 2019 (COVID-19) is an emerging pandemic disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Although the majority of patients who become infected with SARS-CoV-2 are asymptomatic or have mild symptoms, some patients develop severe symptoms that can permanently detract from their quality of life. SARS-CoV-2 is closely related to SARS-CoV-1, which causes severe acute respiratory syndrome (SARS). Both viruses infect the respiratory system, and there are direct and indirect effects of this infection on multiple organ systems, including the musculoskeletal system. Epidemiological data from the SARS pandemic of 2002 to 2004 identified myalgias, muscle dysfunction, osteoporosis, and osteonecrosis as common sequelae in patients with moderate and severe forms of this disease. Early studies have indicated that there is also considerable musculoskeletal dysfunction in some patients with COVID-19, although long-term follow-up studies have not yet been conducted. The purpose of this article was to summarize the known musculoskeletal pathologies in patients with SARS or COVID-19 and to combine this with computational modeling and biochemical signaling studies to predict musculoskeletal cellular targets and long-term consequences of the SARS-CoV-2 infection.

Hali tarjima qilinmagan

Identifikatorlar

Iqtiboslar va manbalar

3 ta iqtibos0 ta foydalanilgan manba